CompletedNCT06790823
Probiotics for depressive symptoms linked to substance use
About this title
Read the official source — NCT06790823Medication studyAges 18–70IranDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- ShirazSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: July 15, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- Shiraz University of Medical Sciences
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Iran
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT06790823
- Official title
Show the full official title
Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Shiraz
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Shiraz University of Medical Sciences, a university.
Did this study involve medication?
Yes. The study involved medication, including The probiotic supplement (Moodamin capsuls) and Placebo.
Who was this study for?
Listed age limits: 18 years to 70 years.
